Collegium Pharmaceutical, Inc Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.25M-0.44M1.71M28.48M280.41M296.70M310.02M276.87M463.93M566.77M631.45M
Cost of Revenue 0.21M2.60M165.68M193.66M130.18M126.25M254.44M240.60M254.10M
Gross Profit 1.50M25.88M114.74M103.04M179.84M150.62M209.49M326.17M377.34M
Operating items
Amortization - Intangibles 109.83M14.75M60.68M67.18M136.25M145.76M165.30M
Research & Development 14.96M7.97M14.95M8.57M8.66M10.34M9.77M9.45M3.98M
Selling, General & Administrative 2.71M18.93M80.63M92.76M126.76M116.45M113.83M118.96M172.19M159.21M210.36M
Restructuring Costs 4.58M33.91M32.32M33.70M
Other Operating Expenses 0.21M2.60M15.02M8.67M-104.14M-15.80M
Operating Expenses 17.66M26.91M95.79M103.92M135.42M126.79M123.60M132.99M176.17M159.21M207.45M
Operating Income -17.66M-26.91M-94.08M-75.45M-20.68M-23.75M56.23M17.63M33.32M166.96M169.90M
EBIT -17.66M-26.91M-94.08M-75.45M-20.68M-23.75M56.23M17.63M33.32M166.96M169.90M
Non-operating items
Interest & Investment Income -0.09M0.58M1.69M1.94M0.23M0.01M1.05M15.62M13.98M
Other Non Operating Income -0.25M-0.35M-0.09M0.58M-23.50M-11.33M
Non Operating Income -0.25M-0.35M-0.09M0.58M
Net income details
EBT -17.92M-27.35M-94.27M-74.86M-39.13M-22.72M27.58M-3.37M-28.85M75.73M98.57M
Tax Provisions 0.83M-74.89M4.71M29.73M56.19M
Profit After Tax -17.92M-27.25M-94.18M-74.86M-39.13M-22.72M26.75M71.52M-25.00M48.16M69.19M
Income from Continuing Operations -17.92M-27.35M-94.27M-74.86M-39.13M-22.72M26.75M71.52M-33.55M46.00M42.38M
Consolidated Net Income -17.92M-27.35M-94.27M-74.86M-39.13M-22.72M26.75M71.52M-33.55M46.00M42.38M
Income towards Parent Company -17.92M-27.35M-94.27M-74.86M-39.13M-22.72M26.75M71.52M-33.55M46.00M42.38M
Net Income towards Common Stockholders -17.92M-27.35M-94.18M-74.86M-39.13M-22.72M26.75M71.52M-33.55M46.00M42.38M
Additional items
EPS (Basic) -22.72-1.48-3.88-2.47-1.19-0.680.782.05-0.741.432.14
EPS (Weighted Average and Diluted) -1.19-0.680.761.86-0.741.291.86
Shares Outstanding (Weighted Average) 19.71M20.69M28.61M32.56M33.25M33.53M34.58M34.57M33.57M32.61M32.25M
EBITDA -17.66M-26.91M-94.08M-75.45M-20.68M-23.75M56.23M17.63M33.32M166.96M169.90M
Interest Expenses 0.25M0.44M0.09M20.13M0.91M28.88M21.01M63.21M83.34M73.97M
Tax Rate 3.01%39.26%57.01%